JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, N. P.
Right arrow Articles by Gould, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, N. P.
Right arrow Articles by Gould, K. L.
Journal of Nuclear Medicine Vol. 46 No. 9 1427-1437
© 2005 by Society of Nuclear Medicine


Clinical Investigations

Clinical Evaluation of a New Concept: Resting Myocardial Perfusion Heterogeneity Quantified by Markovian Analysis of PET Identifies Coronary Microvascular Dysfunction and Early Atherosclerosis in 1,034 Subjects

Nils P. Johnson, MD1 and K. Lance Gould, MD2

1 Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
2 Division of Cardiology, Department of Medicine, The Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Medical School at Houston and the Memorial Hermann Hospital, Houston, Texas

Coronary endothelial dysfunction is an early marker of coronary artery disease (CAD) but its noninvasive assessment is limited. We tested the hypothesis that diffuse patchy heterogeneous resting myocardial perfusion by noninvasive cardiac PET, quantified objectively by Markovian homogeneity analysis, or its improvement during dipyridamole stress, is a predictor of even mild stress perfusion abnormalities, consistent with coronary microvascular dysfunction as an early marker of CAD. Methods: Rest-dipyridamole PET with 82Rb was performed on 1,034 consecutive subjects for possible CAD or follow-up, for second opinion on revascularization procedures, or for screening because of risk factors and on 50 healthy control subjects. Objective, automated software quantified myocardial PET perfusion images for (i) patchy diffuse perfusion heterogeneity by Markovian homogeneity analysis separately from, independently of, and around significant localized regional perfusion defects; (ii) size and severity of localized regional perfusion defects caused by flow-limiting stenosis; and (iii) the graded base-to-apex longitudinal perfusion gradient due to early diffuse CAD without flow-limiting stenosis. History of vascular risk factors was obtained for all subjects. Results: Resting myocardial perfusion heterogeneity with a homogeneity index outside 1 SD of healthy reference subjects and its improvement with dipyridamole correlated closely with CAD documented by stress-induced regional myocardial perfusion abnormalities outside 1 SD independently of other risk factors by multivariate logistic regression analysis (P < 0.001), by multivariate linear regression analysis (P < 0.001), and by {chi}2 analysis (P < 0.001). The relative odds ratios of having stress-induced myocardial perfusion abnormalities for a resting homogeneity index outside 1 SD of healthy reference subjects was highly predictive and substantially greater than for standard risk factors. Conclusion: Patchy heterogeneous resting myocardial perfusion by noninvasive cardiac PET quantified objectively using Markovian homogeneity analysis, and its improvement after dipyridamole, are powerful independent predictors of even mild stress-induced perfusion abnormalities, more than standard risk factors, consistent with coronary microvascular dysfunction as an early marker of preclinical CAD for potential preventive treatment.

Key Words: myocardial perfusion • PET • coronary artery disease • heterogeneity • homogeneity • microvascular function • risk factors


Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 8a-9a. [Full Text]  



This article has been cited by other articles:


Home page
JNMHome page
E. Fricke, S. Eckert, A. Dongas, H. Fricke, R. Preuss, O. Lindner, D. Horstkotte, and W. Burchert
Myocardial Sympathetic Innervation in Patients with Symptomatic Coronary Artery Disease: Follow-up After 1 Year with Neurostimulation
J. Nucl. Med., September 1, 2008; 49(9): 1458 - 1464.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. L. Gould, T. Pan, C. Loghin, N. P. Johnson, and S. Sdringola
Reducing Radiation Dose in Rest-Stress Cardiac PET/CT by Single Poststress Cine CT for Attenuation Correction: Quantitative Validation
J. Nucl. Med., May 1, 2008; 49(5): 738 - 745.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. L. Gould, T. Pan, C. Loghin, N. P. Johnson, A. Guha, and S. Sdringola
Frequent Diagnostic Errors in Cardiac PET/CT Due to Misregistration of CT Attenuation and Emission PET Images: A Definitive Analysis of Causes, Consequences, and Corrections
J. Nucl. Med., July 1, 2007; 48(7): 1112 - 1121.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Loghin, S. Sdringola, and K. L. Gould
Does coronary vasodilation after adenosine override endothelin-1-induced coronary vasoconstriction?
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H496 - H502.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The Year in Cardiac Imaging
J. Am. Coll. Cardiol., December 5, 2006; 48(11): 2324 - 2339.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.